Follow the Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the supervision of HKEX. Market capitalisation: €14.5bn. The latest transaction was disclosed on 25 June 2026 (Purchase). Among the most active insiders: 劉彥君. All data is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€2m
5 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,652 of 29,062 companies
55.3
score / 100
Value
87
Quality
24
FCF yld38%
Earn yld8.3%
EV/EBITDA6.5x
ROE·
Gross mgn18%
Net mgn1.0%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
150,000 shares@ HK$24.3333100.0% of flowShareXHKGHKEX:DA20260518E00030
5 of 5 declarations
About Shanghai Bao Pharmaceuticals Co., Ltd. - B - H Shares
Shanghai Bao Pharmaceuticals Co., Ltd. is a Shanghai-based pharmaceutical company focused on the development and manufacturing of pharmaceutical products. It is listed on the B market of H shares.